The active metabolite of vitamin D 3 , 1 ,25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ), has immunoregulatory, pro-diVerentiating, and antiproliferative properties that have been shown to inhibit the progression of a number of autoimmune diseases, including experimental autoimmune encephalomyelitis 1 and autoimmune diabetes. 2 3 A recent paper by Cantorna et al 4 has shown that 1,25-(OH) 2 D 3 can both prevent the development and halt the progression of arthritis in murine models of the human disease. Oral 1,25-(OH) 2 D 3 treatment has also been shown to improve human psoriatic arthritis, 5 and its analogue 1 -hydroxyvitamin D 3 inhibits type II collagen induced arthritis in rats. 6 Exogenous administration of 1,25-(OH) 2 D 3 may be a useful therapeutic approach for arthritis, however substrate dependent endogenous production of 1,25-(OH) 2 D 3 can occur within the arthritic joint in vivo. 7 8 The source of the extra-renal 1,25-(OH) 2 D 3 is likely to be the synovial macrophage, as we have demonstrated in vitro that macrophages isolated from the synovial fluids of patients with inflammatory arthritis express vitamin-D-1 -hydroxylase (1-OHase) activity, 9 which can be regulated by locally encountered factors such as cytokines, for example, interferon gamma (IFN ), bacterial lipopolysaccharide, and eicosanoids. [10] [11] [12] [13] [14] Another vitamin D hydroxylase enzyme, namely the 24-hydroxylase (24-OHase), is responsible for the catabolism of 1,25-(OH) 2 D 3 , and is expressed by synovial fibroblasts. 13 1,25-(OH) 2 D 3 and its receptor (VDR) bind to the vitamin D response elements (VDREs) of target genes to control their transcription and, as the promoter region of the human 24-OHase gene contains VDREs, 15 it appears that the activity of the synovial fibroblast 24-OHase might be under the control of the local concentration of macrophage derived 1,25-(OH) 2 D 3 .
In this study we wanted to investigate how induction of synovial fibroblast 24-OHase by 1,25-(OH) 2 produced by macrophages when the two cell types were co-cultured, were also investigated using a hydroxylase assay.
Methods

SOURCE OF SYNOVIAL CELLS
Synovial fibroblasts (designated F733), derived from an explant culture from a patient with rheumatoid arthritis, were kindly supplied by Dr David Taylor. Cells were routinely grown in Dulbecco's modified Eagle's medium (DMEM) containing 1 × 10 -3 M sodium pyruvate (Gibco), 2 × 10 -3 M L-glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin, and 10% v/v fetal bovine serum (Imperial) and passaged every 1-2 weeks using 0.25% trypsin, 0.02% w/v EDTA in phosphate buVered saline (Imperial). Cells were used at passage 10 in these experiments.
A primary culture of synovial fluid macrophages was established from the synovial fluid of a patient with rheumatoid arthritis using the method of Hayes et al. 12 Briefly, the synovial fluid sample was diluted in RPMI-1640 culture medium containing 2% v/v fetal bovine serum, 4 × 10 -4 M L-glutamine, 10 IU/ml penicillin, and 10 µg/ml streptomycin. From experience, we have found that incubating the sample in 2% v/v fetal bovine serum, rather than 10% v/v fetal bovine serum, encourages the culture of macrophages, but not fibroblasts, thus allowing fibroblast free cultures of macrophages to be established. Any macrophage culture contaminated by fibroblasts can be readily identified, because fibroblasts proliferate in culture and can be seen as colonies.
The sample was incubated at 37°C in a humidified atmosphere of air with 5% carbon dioxide for 2-3 days; after this time macrophages had adhered to the culture plate surface and non-adherent cells were washed away. All cells from the sample stained positive for nonspecific esterase activity, a marker of monocyte-macrophages. May, cloned into the Pst I site of Bluescript KS+. The in situ hybridisation technique used in this study has previously been described by Mee et al. 17 Controls were sense riboprobe and RNase A treated cells (Sigma; 1 mg/ml in water for one hour at 37°C) to ensure that probe binding to cells was RNA specific. Probe hybridisation was detected by dipping slides in photographic emulsion (Ilford K5) diluted 1:1 with distilled water and developed after seven days at 4°C. The radiation produces silver grains within the emulsion that can be visualised as "black dots" and, as the path length of [
35 S] is 15-20 µm, the positions of the black dots localise the areas of probe binding. Cells were counterstained using eosin and Harris haematoxylin and examined using light field microscopy. Probe hybridisation was quantified with a Quantimet 600 image analyser linked to a Leica DM microscope (Leica UK Ltd), 18 allowing the percentage cell area covered by silver grains to be calculated, corrected for background levels of probe binding.
DETERMINATION OF VITAMIN D HYDROXYLASE
ACTIVITY
EVect of 1,25-(OH) 2 D 3 on synovial fibroblast vitamin D hydroxylase activity
To study the eVects of 1,25-(OH) 2 -3 M L-glutamine, using the hydroxylase assay described previously by Hayes et al. 12 A blank incubation (no cells) was also included in the assay. Metabolites were extracted using chloroform: methanol, 3:2 v/v and quantified using high performance liquid chromatography (HPLC) and liquid scintillation counting. Briefly, the chloroform layer was extracted and analysed on a manual injection normal phase HPLC system developed with a mobile phase of n-hexane:isopropanol:methanol, 115:3.3:4 (v/v) at 2 ml/min and a Zorbax-Sil column (4.6 mm × 25 cm). Eluant fractions were collected, the radioactivity measured, and the known specific activity of substrate used to calculate the rate of synthesis of vitamin D 3 metabolites in each sample. An aliquot of the upper aqueous phase of the extraction mixture was also counted as a measure of more polar metabolites.
Synovial macrophages and fibroblasts in co-culture
A co-culture system was established to determine whether synovial macrophage derived 1,25-(OH) 2 D 3 could be directly 24-hydroxylated by F733 in vitro to form 1,24,25-(OH) 3 D 3 . F733 were grown in sterile 12 mm diameter polystyrene well inserts (Costar), which could fit into the wells of a 12 well tissue culture dish (Corning) in which the macrophages were cultured. The inserts had a 3.0 µm porous membrane that allowed the culture medium to move freely between the chambers. Adequate synthesis of 1,25-(OH) 2 D 3 by macrophages was ensured by pre-treatment for 24 hours with 5 × 10 -9 M interferon gamma (IFN ; Advanced Protein Products Ltd). After (fig 1 (A-C) ) Pre-treatment with 1,25-(OH) 2 (fig 1(B) ). Both RNase A treated control slides (fig 1(C) ) and sense riboprobe control slides showed only background levels of silver grains. (fig 1 (D-F) ) There was an increase in probe binding to (fig 1(D) ; p < 0.01) and five hour treatment values (p < 0.01). Again, both RNase A treated control slides (fig 1(F) and sense riboprobe control slides showed only background levels of silver grains.
VDR mRNA
EXPRESSION OF VITAMIN D HYDROXYLASE ACTIVITY (FROM HYDROXYLASE ASSAYS)
Metabolism of [ 3 H]-25-(OH)D 3 by synovial fibroblasts pre-treated with 1,25-(OH) 2 D 3
The HPLC trace in fig 2(A) figure 2 (A) An aliquot of the aqueous phase was added to scintillation cocktail and [
H]-25-(OH)D 3 and (B) [ 3 H]-1,25-(OH) 2 D 3 metabolism. HPLC conditions are as described in Methods. The dotted traces show the positions of known tritiated forms of 25-(OH)D 3 (peak A), 24,25-(OH) 2 D 3 (peak B), and 1,25-(OH) 2 D 3 (peak C). As no radioactive tracer was available, the expected position of a tritiated 1,24,25-(OH) 3 D 3 peak was calculated using an ultraviolet trace of unlabelled markers in conjunction with the radioactive trace above. The solid trace in
3 H] dpm measured. The unidentified radioactivity present in the aqueous phase of the extraction mixture (corrected from the blank (no cells) incubation) increased with 1,25-(OH) 2 D 3 pretreatment concentration (fig 3 (C) ). This radioactivity indicates the presence of more polar products than those found in the chloro- form layer, however the number and nature of metabolites present in the aqueous phase was not determined.
Metabolism of [ 3 H]-1,25-(OH) 2 D 3 by synovial fibroblasts pre-treated with 1,25-(OH) 2 D 3
The HPLC trace in figure 2 (B) 3 D 3 to further catabolic products, which would explain the much higher counts in the aqueous phase seen with these two treatment points (fig 3 (F) ). 1,25-(OH) 2 D 3 pre-treatment had no significant eVect on the synthesis of the unidentified more polar metabolite (peak F in fig 2 (B), and fig 3 (E) ). We have previously studied the eVect of 1,25-(OH) 2 D 3 on 24-OHase activity and mRNA in a variety of rheumatoid synovial fibroblast cell lines, and on the same lines at diVerent passage numbers, and always found a stimulatory eVect on both 24-hydroxylase and mRNA levels-so much so, that fibroblast cell lines are used as reliable positive controls in house for the in situ hybridisation method. We have not studied fibroblasts from osteoarthritic synovium, however it would be interesting to see if there were diVerences in the expression of these molecules in the diVerent disease states, particularly as we have previously shown a difference in endogenous 1,25-(OH) 2 D 3 synthesis in rheumatoid and osteoarthritis. 8 Once the stimulatory eVect of exogenous 1,25-(OH) 2 D 3 on fibroblast 24-OHase had been established, we examined the metabolism of 25-(OH)D 3 by macrophages and fibroblasts in co-culture. We have now demonstrated that synovial fibroblasts can metabolise macrophage derived 1,25-(OH) 2 D 3 to 1,24,25-(OH) 3 D 3 , and more polar metabolites in exactly the same way as exogenous 1,25-(OH) 2 D 3 , confirming the hypothesis that fibroblasts are able to regulate the concentration of locally synthesised 1,25-(OH) 2 D 3 in vitro.
Vitamin D metabolism in synovial macrophages and fibroblasts in co-culture
Our experiments also indicate that a relatively small number of macrophages (2.18 × 10 5 cells per incubation) have the ability to make a large amount of 1,25-(OH) 2 D 3 . The concentration of substrate 25-(OH)D 3 used in the co-culture system was physiological (12.5 ng/ml or 3.125 × 10 -8 M) and resulted in 1,25-(OH) 2 D 3 concentrations of approximately 6 × 10 -9 M and 1.7 × 10 -8 M in control and IFN stimulated cultures respectively after 24 hours. As the normal serum concentration of 1,25-(OH) 2 D 3 is in the order of 10 -10 M to 10 -11 M (20-50 pg/ml; from Mawer et al 19 ) , it is theoretically possible that, unless regulated, high concentrations of 1,25-(OH) 2 D 3 could be synthesised in the joint within a relatively short time period. The concentration of macrophage derived 1,25-(OH) 2 D 3 was reduced to 6 × 10 -9 M in the co-culture incubation (24 hour incu- Results are expressed as mean (SEM), n=3; nd=none detected. The co-culture incubation consisted of F733 (untreated) and IFN pre-treated macrophages.
